How does protein binding affect volume of distribution?
Decreased plasma protein binding leads to an increase in free plasma fraction causing an increase in volume of distribution and a shorter elimination half life. The increase in the apparent volume of distribution and the shorter elimination half life cause a decrease in total plasma concentration.
What is steady state volume of distribution?
Steady-state volume of distribution (Vss) Vss describes the volume of distribution during steady state conditions, i.e. when there is a stable drug concentration. The loading dose, after all, is the dose you wish to give in order to achieve a desired (steady state) drug concentration.
What does it mean when a drug reaches steady state?
Following repeated administration of a drug, a steady-state is reached when the quantity of drug eliminated in the unit of time equals the quantity of the drug that reaches the systemic circulation in the unit of time.
What increases distribution volume?
Volume of distribution may be increased by kidney failure (due to fluid retention) and liver failure (due to altered body fluid and plasma protein binding). Conversely it may be decreased in dehydration.
What is the role of protein binding in drug distribution?
Protein binding can influence the drug’s biological half-life. The bound portion may act as a reservoir or depot from which the drug is slowly released as the unbound form. Since the unbound form is being metabolized and/or excreted from the body, the bound fraction will be released in order to maintain equilibrium.
What is drug volume distribution?
The volume of distribution (VD) relates the amount of drug in the body to the concentration of drug in the plasma. It is calculated by dividing the dose that ultimately gets into the systemic circulation by the plasma concentration at time zero (Cp0): (1)
How do you find the volume of distribution at steady state?
The following equation, V(ss) = (D/AUC)*MRT(int), was obtained, where AUC is the commonly calculated area under the time curve of the total drug concentration in plasma after intravenous (iv) administration of bolus drug dose, D, and MRT(int) is the intrinsic mean residence time, which is the average time the drug …
What two factors can change the volume of distribution?
Factors that affect the volume of distribution include plasma protein binding, obesity, edema, and tissue binding.
What are the two important parameters of protein binding?
The protein binding, as well as plasma pH between the maternal and fetal compartment, are the two critical factors, which usually are responsible for exhibiting a difference in the concentration of drug in both the compartments.
What happens when a drug binds to protein?
How does plasma protein binding affect the distribution of drugs?
The distribution of drug from plasma to target tissues can be effected by a number of factors, such as high molecular wight, but perhaps the most important is Plasma Protein Binding (PPB).
Are there drug-drug interactions with highly protein bound drugs?
Drugs can compete for the same binding site and thus there is the potential for drug-drug interactions, this would be a particular concern for highly protein bound drugs that have a low therapeutic index such as warfarin.
What determines the distribution of drugs in the body?
The distribution of drugs in the body depends on their lipophilicity and protein binding. Low plasma binding or high tissue binding or high lipophilicity usually means an extensive tissue distribution. In pharmacokinetics, the distribution is described by the parameter V, the apparent volume of distribution.
How does lipophilicity affect the distribution of drugs?
The distribution of drugs in the body depends on their lipophilicity and protein binding. Low plasma binding or high tissue binding or high lipophilicity usually means an extensive tissue distribution. In pharmacokinetics, the distribution is described by the parameter V, the apparent volume of dist …
